Medigus Accounts Payable

Medigus (MDGS) currently reports a accounts payable of $13M as of December 2023. That compares with $20M in the prior-year period — down 35.1% year over year. Use the charts on this page to explore Medigus's accounts payable history and peer comparisons.

Medigus's accounts payable decreased from $20M to $13M — a 35.1% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medigus reported $13M in accounts payable as of December 2023. That compares with $20M in the prior-year period — down 35.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medigus, and consider following MDGS for alerts when major investors trade the stock.

Medigus is classified in the Healthcare sector. On accounts payable, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDGS with unrelated industries.